Casdin Partners GP, LLC 4
4 · GeneDx Holdings Corp. · Filed May 15, 2024
Insider Transaction Report
Form 4
Casdin Capital, LLC
Director10% Owner
Transactions
- Purchase
Class A Common Stock
2024-05-13$23.31/sh+50,000$1,165,295→ 2,753,509 total
Holdings
- 3,142
Class A Common Stock
- 333,144(indirect: See footnote)
Class A Common Stock
- 432,902(indirect: See footnote)
Class A Common Stock
Footnotes (4)
- [F1]The securities are owned directly by Casdin Partners Master Fund, L.P. (the "Master Fund") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC, the investment adviser to the Master Fund ("Casdin"), (ii) Casdin Partners GP, LLC, the general partner of the Master Fund (the "GP"), and (iii) Eli Casdin, the managing member of Casdin and the GP.
- [F2]The securities are owned directly by Eli Casdin.
- [F3]The securities are owned directly by Casdin Partners FO1-MSV, LP ("Casdin FO1") and may be deemed to be indirectly beneficially owned by (i) Casdin, the investment adviser to Casdin FO1, (ii) the GP, the general partner of Casdin FO1, and (iii) Eli Casdin, the managing member of Casdin Capital, LLC and Casdin Partners GP, LLC.
- [F4]The securities are owned directly by CMLS Holdings LLC ("CMLS Holdings"). The Board of Managers of CMLS Holdings includes Eli Casdin, who, as a member of the Board of Managers of CMLS Holdings, shares voting and investment discretion with respect to the common stock held by CMLS Holdings.